Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q4	-- / 770.000M	--
Feb 13, 2025	2025/Q3	-- / 757.000M	--
Nov 12, 2024	2025/Q2	695.000M / 722.000M	--
Aug 7, 2024	2025/Q1	678.000M / 700.000M	--
May 14, 2024	2024/Q4	597.000M / 686.000M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q4-- / 770.000M--

Feb 13, 20252025/Q3-- / 757.000M--

Nov 12, 20242025/Q2695.000M / 722.000M--

Aug 7, 20242025/Q1678.000M / 700.000M--

May 14, 20242024/Q4597.000M / 686.000M--

Unlock Free Earnings Estimates

Open Account

StemCell Institute Earnings Reports

StemCell Institute: Confirmation letter

Nov 14, 2024 01:33 ET

StemCell Institute: Half Year Report - Term 26 (2024/04/01 - 2025/03/31)

Nov 14, 2024 01:31 ET

StemCell Institute: Summary of financial results for the 2nd quarter (interim period) for the fiscal year ending March 31, 2025 [Japanese GAAP] (unconsolidated)

Nov 12, 2024 01:30 ET

StemCell Institute: Financial results briefing materials for the 2nd quarter (interim period) of the fiscal year ending March 31, 2025

Nov 12, 2024 01:30 ET

Symbol Price % Chg